Testing for gene mutations linked to breast and ovarian cancer is rare among some Medicare patients who have the cancers and qualify for such tests, a new study found. Researchers analyzed data from 12 southeastern states between 2000 and 2014. Only eight percent of 92 women who met Medicare criteria for BRCA1 and BRCA2 gene...Read More